⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SXTP News
60 Degrees Pharmaceuticals, Inc. Common Stock
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
SXTP
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
globenewswire.com
SXTP
Form 8-K
sec.gov
SXTP
SXTPW
Form 8-K
sec.gov
SXTP
SXTPW
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
globenewswire.com
SXTP
60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026
globenewswire.com
SXTPW
SXTP
Form 8-K
sec.gov
SXTPW
SXTP
Form 8-K
sec.gov
SXTP
SXTPW
60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases
globenewswire.com
SXTP
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue
globenewswire.com
SXTP